Bruker (BRKRP) FCF Payout Ratio Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.45% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -51.96% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9,472.45% |
| 10 | Bruker | - | - | 379.80 Mn | 18.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.54% |
| Dec 31, 2025 | 124.55% |
| Sep 30, 2025 | -110.72% |
| Jun 30, 2025 | 84.41% |
| Mar 31, 2025 | -98.92% |
| Dec 31, 2024 | -451.39% |
| Sep 30, 2024 | 204.57% |
| Jun 30, 2024 | -1,046.81% |
| Mar 31, 2024 | 15,313.85% |
| Dec 31, 2023 | -22.39% |
| Sep 30, 2023 | -31.40% |
| Jun 30, 2023 | 76.27% |
| Mar 31, 2023 | -7.17% |
| Dec 31, 2022 | -0.72% |
| Sep 30, 2022 | -73.81% |
| Jun 30, 2022 | -101.38% |
| Mar 31, 2022 | 53.27% |
| Dec 31, 2021 | 55.48% |
| Sep 30, 2021 | 796.99% |
| Jun 30, 2021 | 1,381.43% |
| Mar 31, 2021 | -93.96% |
| Dec 31, 2020 | -39.00% |
| Sep 30, 2020 | 55.88% |
| Jun 30, 2020 | 169.09% |
| Mar 31, 2020 | -21.27% |
| Sep 30, 2019 | 123.77% |
| Jun 30, 2019 | -472.12% |
| Mar 31, 2019 | 880.56% |
| Sep 30, 2018 | -47.03% |
| Jun 30, 2018 | 1,326.27% |
| Mar 31, 2018 | -41.16% |
| Dec 31, 2017 | 267.20% |
| Sep 30, 2017 | -1,997.15% |
| Jun 30, 2017 | -102.55% |
| Mar 31, 2017 | 202.66% |
| Dec 31, 2016 | -2,917.75% |